-
0
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2022-11-30 19:00:00
Did you know that nearly all NRG1 gene fusions contain NRG1 exon 6?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Non-Alcoholic Fatty Liver Disease
5000208
global
1
0.5
9
0.5
0.5
Clinical Review
0
1
Gastroenterology2022-11-30 19:00:00
Non-alcoholic fatty liver disease (NAFLD) is present in 1 in 4 people. Learn how to assess risk for liver fibrosis in your patients with NAFLD in this video lecture.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
0
global
1
1.0
9
1.0
2
1.0
3
1.0
1.0
Roundtable
0
1
Hematology-Oncology2022-11-30 19:00:00
Are you looking to get up to speed about emerging research on ctDNA, systemic therapy, and managing toxicity in early-stage triple negative breast cancer? Learn more here.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Cardiovascular Imaging
6000091
global
1
1.25
9
1.25
1.25
Roundtable
0
1
Cardiology2022-11-30 19:00:00
Curious about COVID-19 and pericarditis? Experts discuss timely assessment and management of pericarditis, the latest data, and challenging patient cases.
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Advanced and Metastatic Breast Cancer
846
global
1
1.25
9
1.25
2
1.25
3
1.25
1.25
Roundtable
0
1
Hematology-Oncology2022-11-30 19:00:00
Are you up to date on the latest data regarding metastatic HER2-positive breast cancer?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Breast Cancer
840
global
1
1.5
9
1.5
2
1.5
3
1.5
1.5
Roundtable
0
1
Hematology-Oncology2022-11-30 19:00:00
Top breast cancer experts cover the latest data on brain metastases in breast cancer, HER2-low breast cancer and HER2 testing.
1.5ABIM MOC
1.5CME/CE
90MIN
Save
-
0
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2022-11-30 19:00:00
Did you know that nearly all NRG1 gene fusions contain NRG1 exon 6?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Non-Alcoholic Fatty Liver Disease
5000208
global
1
0.5
9
0.5
0.5
Clinical Review
0
1
Gastroenterology2022-11-30 19:00:00
Non-alcoholic fatty liver disease (NAFLD) is present in 1 in 4 people. Learn how to assess risk for liver fibrosis in your patients with NAFLD in this video lecture.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
0
global
1
1.0
9
1.0
2
1.0
3
1.0
1.0
Roundtable
0
1
Hematology-Oncology2022-11-30 19:00:00
Are you looking to get up to speed about emerging research on ctDNA, systemic therapy, and managing toxicity in early-stage triple negative breast cancer? Learn more here.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Cardiovascular Imaging
6000091
global
1
1.25
9
1.25
1.25
Roundtable
0
1
Cardiology2022-11-30 19:00:00
Curious about COVID-19 and pericarditis? Experts discuss timely assessment and management of pericarditis, the latest data, and challenging patient cases.
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Advanced and Metastatic Breast Cancer
846
global
1
1.25
9
1.25
2
1.25
3
1.25
1.25
Roundtable
0
1
Hematology-Oncology2022-11-30 19:00:00
Are you up to date on the latest data regarding metastatic HER2-positive breast cancer?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Breast Cancer
840
global
1
1.5
9
1.5
2
1.5
3
1.5
1.5
Roundtable
0
1
Hematology-Oncology2022-11-30 19:00:00
Top breast cancer experts cover the latest data on brain metastases in breast cancer, HER2-low breast cancer and HER2 testing.
1.5ABIM MOC
1.5CME/CE
90MIN
Save
-
Parkinson Disease
907
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Neurology & Neurosurgery2022-11-30 19:00:00
When is it time to treat Parkinson disease psychosis (PDP)? What are the options? Drs Grossberg and Pahwa discuss considerations in management.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Peripheral Artery Disease
419
global
1
0.25
9
0.25
0.25
Commentary
0
1
Cardiology2022-11-30 19:00:00
Would you like to know more about assessing and screening the right patients for peripheral artery disease?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
0
global
1
0.5
9
0.5
2
0.5
0.5
Roundtable
0
1
Plastic Surgery & Aesthetic Medicine2022-11-30 19:00:00
Do you know how to advise your patients to protect their skin against environmental aggressors?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Breast Cancer
840
global
1
1.5
9
1.5
2
1.5
3
1.5
1.5
Roundtable
0
1
Hematology-Oncology2022-11-30 19:00:00
Did you know that approximately 65% to 70% of all breast cancers express hormone receptors in the absence of HER2 amplification?
1.5ABIM MOC
1.5CME/CE
90MIN
Save
-
Acute Leukemia
5005273
global
1
0.5
9
0.5
2
0.5
0.5
Roundtable
0
1
Hematology-Oncology2022-11-29 19:00:00
Do you want to help patients with acute lymphoblastic leukemia (ALL) to transplant? Join for insight into how to maximize therapies and mitigate adverse events (AEs) to optimize transplant eligibility.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Basal Cell Carcinoma
59
global
1
0.75
9
0.75
0.75
Roundtable
0
1
Dermatology2022-11-29 19:00:00
How do you handle patients with basal cell carcinoma (BCC) when surgery isn’t the best option?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Breast Cancer
840
global
1
1.0
9
1.0
1.0
Roundtable
0
1
Radiology2022-11-29 19:00:00
Are you using magnetic resonance imaging (MRI) in your practice to assess treatment response to neoadjuvant therapy? If not, maybe you should.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Skeletal Dysplasia
5001766
global
1
0.75
9
0.75
0.75
Roundtable
0
1
Pediatrics2022-11-29 19:00:00
A multidisciplinary and pro-active approach is critical for the care of medical, functional and psychosocial issues that can occur throughout life in individuals with achondroplasia.
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Psoriasis
29
global
1
0.75
9
0.75
2
0.75
0.75
Roundtable
0
1
Dermatology2022-11-29 19:00:00
What’s the latest in topical treatments for psoriasis? Experts discuss strategies to optimize care for patients.
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Breast Cancer
840
global
1
1.75
9
1.75
2
1.75
3
1.75
1.75
Roundtable
0
1
Hematology-Oncology2022-11-29 19:00:00
Did you know that about 20% of HR-positive HER2-negative EBCs are primary endocrine therapy-resistant and have high risk of early recurrence?
1.75ABIM MOC
1.75CME/CE
105MIN
Save
-
Breast Cancer
840
global
1
2.5
9
2.5
2
2.5
2.5
Roundtable
0
1
Radiology2022-11-29 19:00:00
How are you identifying patients at increased risk for breast cancer and how are you mitigating that risk?
2.5ABIM MOC
2.5CME/CE
150MIN
Save
-
Mantle Cell Lymphoma
5000612
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2022-11-29 19:00:00
Did you know that the emerging non-covalent BTK inhibitors reversibly bind to BTK?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
